JSPR
Jasper TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
JSPR vs peer average
33/100
JSPR vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AKTX is the first available peer comparator.
Loose micro-cap biotech peer; useful mainly for financing sensitivity and event-driven volatility, not for indication-level read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JSPR
Jasper Therapeutics
AKTX
Akari Therapeutics
Grade
F
F
Momentum
61
40
Value
41
42
Sentiment
2
26
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AKTX
JSPR / AKTX
Grade Position
Below peers
JSPR vs. peer average (F vs. D)
33/100
Momentum
61
JSPRValue
41
AKTXSentiment
2
AKTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JSPR
AKTX is the first peer returned for this comparison set.